Headlands Research opens purpose-built clinical trial site in Bellingham, Washington

• Headlands Research opened a purpose-built clinical research site in Bellingham, Washington, expanding its Pacific Northwest footprint.
• The site targets CNS trials, giving sponsors access to more than 615,000 potential participants within a 50-mile radius.
• Board-certified psychiatrist Matthew Bogoyas will serve as principal investigator, with Phase 2 and Phase 3 experience in depression and PTSD studies.
• The launch extends a broader expansion strategy that also includes a recent acquisition adding sites in Sacramento and Lincoln, California.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Headlands Research Inc. published the original content used to generate this news brief on August 05, 2026, and is solely responsible for the information contained therein.